Healthcare, Automotive Feb 14, 2022 06:30 PM (GMT+8) · EqualOcean
Kangzhi pharmaceutical announced that it signed a research cooperation agreement with Guangdong Institute of public health on sulamin sodium for injection, and entrusted Guangdong Institute of public health to study the inhibitory effect of sulamin sodium on different sars-cov-2 virus variants and its minimum effective concentration.
Related companies: